Drug Safety: Teva’s Top Priority
As a leading pharmaceutical company, Teva’s top priority is ensuring the safety and effectiveness of our medicines. Our commitment starts in the research laboratory, where Teva scientists engineer generic, innovative branded and biologic medications designed to improve patient health. It continues throughout the manufacturing process and supply chain where numerous safeguards are included to ensure the highest quality and reliability.
Drug Review & Approval
The U.S. Food and Drug Administration (FDA) oversees a rigorous evaluation process that scrutinizes everything about new drugs developed by Teva – from product ingredient supplies to the design of clinical trials to the severity of side effects to the conditions under which the drug is manufactured. In order to produce affordable generic versions of brand medications, Teva must demonstrate that the generic has the:
- Same active ingredient
- Same labeling and usage
- Same dosage strength
- Same quality and stability
- Same safety and effectiveness demonstrated through bioequivalence testing as the brand-name drug
FDA review and approval is required for all medications and demonstrates that they have met the highest standards for consumer protection.
“The generic version works like the brand-name drug in dosage, strength, performance and use, and must meet the same quality and safety standards.” – FDA website